title: Continuous lamivudine treatment in an OLT patient despite the appearance of HBV resistant strain: longitudinal analysis.
authors.forename: F
authors.initials: F
authors.lastname: Torre
authors.forename: N
authors.initials: N
authors.lastname: Campo
authors.forename: N
authors.initials: N
authors.lastname: Sinelli
authors.forename: R
authors.initials: R
authors.lastname: Brizzolara
authors.forename: E
authors.initials: E
authors.lastname: Andorno
authors.forename: U
authors.initials: U
authors.lastname: Valente
authors.forename: A
authors.initials: A
authors.lastname: Picciotto
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006509:Hepatitis B / Q000276:immunology*; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects; D019259:Lamivudine / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged
chemical_list: D000998:Antiviral Agents; D019259:Lamivudine